Finepoint Capital Lp Top Holdings and 13F Report (2023)

→ The attacks will come for me after releasing this… (From Porter & Company) (Ad)

About Finepoint Capital Lp

Investment Activity

Finepoint Capital Lp has $389.94 million in total holdings as of December 31, 2022.
Finepoint Capital Lp owns shares of 26 different stocks, but just 11 companies or ETFs make up 80% of its holdings.
Approximately 41.02% of the portfolio was purchased this quarter.
About 31.74% of the portfolio was sold this quarter.
This quarter, Finepoint Capital Lp has purchased 27 new stocks and bought additional shares in 11 stocks.
Finepoint Capital Lp sold shares of 2 stocks and completely divested from 5 stocks this quarter.

Largest Holdings

Liberty Broadband: $107,950,660
SpringWorks Therapeutics: $29,164,228
Ascendis Pharma A/S: $26,556,336
Arvinas: $22,254,048
Revolution Medicines: $21,822,933

Largest New Holdings this Quarter

argenx: $19,686,000 Holding
EyePoint Pharmaceuticals: $13,571,922 Holding
DISH NETWORK CORPORATION: $13,450,500 Holding
MONEYHERO LIMITED: $108,474 Holding

Largest Purchases this Quarter

Liberty Broadband: 1,701,800 shares (about $97.39M)
argenx: 50,000 shares (about $19.69M)
EyePoint Pharmaceuticals: 656,600 shares (about $13.57M)
DISH NETWORK CORPORATION: 18,300,000 shares (about $13.45M)
Revolution Medicines: 60,000 shares (about $1.93M)

Largest Sales this Quarter

MoonLake Immunotherapeutics: 534,084 shares (about $26.83M)
Cytokinetics: 193,647 shares (about $13.58M)

Sector Allocation Over Time

Selling

Neutral

Buying

Latest 13F Holdings and Changes Since Previous Quarterly Filing

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
LBRDK Liberty Broadband	$107,950,660	$97,394,014 ▲	922.6%	1,886,260	27.7%	Consumer Discretionary
SWTX SpringWorks Therapeutics	$29,164,228	$1,752,232 ▲	6.4%	592,528	7.5%	Medical
ASND Ascendis Pharma A/S	$26,556,336	$1,798,923 ▲	7.3%	175,672	6.8%	Medical
ARVN Arvinas	$22,254,048	$1,420,032 ▲	6.8%	539,100	5.7%	Medical
RVMD Revolution Medicines	$21,822,933	$1,933,800 ▲	9.7%	677,100	5.6%	Medical
SRPT Sarepta Therapeutics	$20,513,843	$1,695,926 ▲	9.0%	158,457	5.3%	Medical
ARGX argenx	$19,686,000	$19,686,000 ▲	New Holding	50,000	5.0%	Medical
MLTX MoonLake Immunotherapeutics	$18,128,811	$26,827,040 ▼	-59.7%	360,916	4.6%	Medical
CYTK Cytokinetics	$16,689,405	$13,576,591 ▼	-44.9%	238,046	4.3%	Medical
GLPG Galapagos	$16,221,040	$1,452,220 ▲	9.8%	503,759	4.2%	Medical
ACAD ACADIA Pharmaceuticals	$15,539,976	$1,309,092 ▲	9.2%	840,453	4.0%	Medical
EYPT EyePoint Pharmaceuticals	$13,571,922	$13,571,922 ▲	New Holding	656,600	3.5%	Medical
DISH NETWORK CORPORATION	$13,450,500	$13,450,500 ▲	New Holding	18,300,000	3.4%	NOTE 12/1
SLDB Solid Biosciences	$12,803,863		0.0%	961,251	3.3%	Medical
TVTX Travere Therapeutics	$12,715,494	$1,649,169 ▲	14.9%	1,649,221	3.3%	Medical
RLAY Relay Therapeutics	$12,368,411	$1,430,090 ▲	13.1%	1,490,170	3.2%	Medical
PRTA Prothena	$9,967,448	$1,315,287 ▲	15.2%	402,400	2.6%	Medical
CHURCHILL CAPITAL CORP VII	$175,360		0.0%	548,000	0.0%	*W EXP 02/29/202
MONEYHERO LIMITED	$108,474	$108,474 ▲	New Holding	895,000	0.0%	*W EXP 09/13/202
CLDI Calidi Biotherapeutics	$70,625		0.0%	125,000	0.0%	Medical
CONCORD ACQUISITION CORP II	$45,447		0.0%	408,333	0.0%	*W EXP 99/99/999
CDAQW Compass Digital Acquisition	$42,311		0.0%	459,906	0.0%	Financial Services
CALIDI BIOTHERAPEUTICS INC	$34,070		0.0%	655,200	0.0%	*W EXP 03/14/202
IVCPW Swiftmerge Acquisition	$27,391		0.0%	490,000	0.0%	Financial Services
YSBPW YS Biopharma	$24,990		0.0%	489,999	0.0%	Medical
GATEW Marblegate Acquisition	$8,232		0.0%	735,000	0.0%	Financial Services
SAVE Spirit Airlines	$0	$27,863,000 ▼	-100.0%	0	0.0%	Transportation
FOLD Amicus Therapeutics	$0	$21,129,265 ▼	-100.0%	0	0.0%	Medical
HPLTW Home Plate Acquisition	$0	$20,014,212 ▼	-100.0%	0	0.0%	Financial Services
MORF Morphic	$0	$14,349,201 ▼	-100.0%	0	0.0%	Medical
ROSS ACQUISITION CORP II	$0	$24,621 ▼	-100.0%	0	0.0%	*W EXP 02/01/202